Marleen J. A. Simmelink

Author

Also Known As

M.J.A. Simmelink, Marleen J. A. Simmelink, Marleen J.A Simmelink, Marleen Simmelink

Publications

351

Citations

H-Index

Concepts

All Affiliations

Marleen J. A. Simmelink is an author at Utrecht University specializing in thrombosis, immunology, and autoimmunity.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	100
2	Immunology	2	2	100
3	Autoimmune Disease	2	2	100
4	Autoimmunity	2	2	100
5	Hematology	2	2	100

Marleen J. A. Simmelink

Publications

334

Citations

H-Index

Page 1

	Year	Citations
Induction of Functional IL-8 Receptors by IL-4 and IL-13 in Human Monocytes Raffaella Bonecchi, Fabio Facchetti, Stefano Dusi, The Journal of Immunology	2000	133
Complexes of anti‐prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces Marleen J. A. Simmelink, D. A. Horbach, Ronald H. W. M. Derksen, British Journal of Haematology	2001	78
A simple method to discriminate between β2-glycoprotein I- and prothrombin-dependent lupus anticoagulants Marleen J. A. Simmelink, R. H. W. M. Derksen, Jozef Arnout, Journal of Thrombosis and Haemostasis ThrombosisAutoimmune DiseaseSimple MethodBlood PlateletLupus	2003	77
A study on associations between antiprothrombin antibodies, antiplasminogen antibodies and thrombosis Marleen J. A. Simmelink, Philip G. de Groot, R. H. W. M. Derksen Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisAntiplasminogen AntibodiesVenous ThrombosisAutoimmune Disease	2003	23
Oral anticoagulation reduces activated protein C less than protein C and other vitamin K–dependent clotting factors Marleen J. A. Simmelink, Philip G. de Groot, Ronald H. W. M. Derksen, Blood	2002	13
Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II Marleen J. A. Simmelink, José A. Fernández, Ronald H. W. M. Derksen, British Journal of Haematology	2002	10

Page 1